FORM 8-K

Company

Protagenic Therapeutics, Inc.\new

Filed

September 9, 2015

Period of Report

September 3, 2015

Accession Number

0001144204-15-054239

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →